Literature DB >> 6772675

Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.

S J Maturlo, R L Rosenbaum, C Pan, M I Surks.   

Abstract

Although a normal serum thyrotropin (TSH) concentration is generally considered to be the most important finding to support the clinical impression of euthyroidism in patients with nonthyroidal diseases and decreased serum triiodothyronine (T(3)), the regulation of TSH secretion in sick patients has not been studied previously. Accordingly, we studied the regulation of TSH secretion in 23 patients with nonthyroidal diseases; 15 of the patients had decreased serum T(3). TSH regulation was studied by measuring the TSH response to injected thyrotropin-releasing hormone (TRH) before and after effecting a small decrease in serum thyroxine (T(4)) and/or T(3) concentrations by iodide treatment, 262 mg daily for 10 d. Iodide treatment significantly decreased (> 10%) the free T(4) index (FT(4)-I) and/or free T(3) index (FT(3)-I) in all patients. FT(4)-I values were correlated (0.611, P < 0.001), with free T(4) concentration determined by equilibrium dialysis. Despite decreased FT(4)-I and/or FT(3)-I after iodide treatment in all patients, the TSH response to TRH after iodide treatment was augmented in only 8 of 15 patients who had decreased serum T(3) (group 1) and in only 5 of 8 patients who had a normal serum T(3). Mean base-line TSH concentration was increased significantly (P < 0.05) from 0.9+/-0.1 to 1.5+/-0.3 muU/ml in group 1 only. Comparison of the mean TSH response to TRH showed that there was no significant difference between groups 1 and 2. Moreover, no significant difference in thyroidal parameters was observed between patients who had augmented TSH response to TRH after iodides and those who had either similar or decreased TSH response irrespective of the initial serum T(3). These studies show that an augmented TSH response to TRH in response to a small reduction in serum T(4) and T(3) concentration occurred in only 57% of the entire group of patients with nonthyroidal diseases and that the presence or absence of a normal TSH response to this stimulus did not seem to be related to the base-line serum T(3) concentration. Because an increase in serum TSH in response to decreased serum T(4) and T(3) did not occur in about one-half of patients with nonthyroidal diseases, normal serum TSH may not be a reliable index of the euthyroid state in these patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772675      PMCID: PMC371672          DOI: 10.1172/JCI109875

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Diagnostic value of thyrotrophin-releasing hormone in pituitary and hypothalamic diseases. Assessment of thyrotrophin and prolactin secretion in 100 patients.

Authors:  P J Snyder; L S Jacobs; M M Rabello; F H Sterling; R N Shore; R D Utiger; W H Daughaday
Journal:  Ann Intern Med       Date:  1974-12       Impact factor: 25.391

2.  Effect of severe, chronic illness on thyroid function.

Authors:  J N Carter; C J Eastman; J M Corcoran; L Lazarus
Journal:  Lancet       Date:  1974-10-26       Impact factor: 79.321

3.  Tissue thyroid hormone concentration of rat and man determined by radiommunoassay: biologic significance.

Authors:  S Reichlin; J Bollinger; I Nejad; P Sullivan
Journal:  Mt Sinai J Med       Date:  1973 May-Jun

Review 4.  Studies of thyrotropin physiology by means of radioimmunoassay.

Authors:  W D Odell; J F Wilber; R D Utiger
Journal:  Recent Prog Horm Res       Date:  1967

5.  Alterations in circulating thyroid hormones and thyrotropin in hepatic cirrhosis: evidence for euthyroidism despite subnormal serum triiodothyronine.

Authors:  I J Chopra; D H Solomon; U Chopra; R T Young; G N Chua Teco
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

6.  Response to thyrotropin releasing hormone (TRH) in normal man.

Authors:  P J Snyder; R D Utiger
Journal:  J Clin Endocrinol Metab       Date:  1972-02       Impact factor: 5.958

7.  Utility of the radioimmunoassay of serum thyrotrophin in man.

Authors:  J M Hershman; J A Pittman
Journal:  Ann Intern Med       Date:  1971-04       Impact factor: 25.391

8.  A new radioimmunoassay for plasma L-triiodothyronine: measurements in thyroid disease and in patients maintained on hormonal replacement.

Authors:  M I Surks; A R Schadlow; J H Oppenheimer
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

9.  Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones.

Authors:  P J Snyder; R D Utiger
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

10.  Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations.

Authors:  A G Vagenakis; B Rapoport; F Azizi; G I Portnay; L E Braverman; S H Ingbar
Journal:  J Clin Invest       Date:  1974-10       Impact factor: 14.808

View more
  7 in total

Review 1.  Hormonal changes in non-endocrine disease.

Authors:  C G Semple
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

2.  Importance of specific reference values for evaluation of the deteriorating thyroid function in patients with end-stage renal disease on hemodialysis.

Authors:  Toru Sanai; Ken Okamura; Tomoya Kishi; Motoaki Miyazono; Yuji Ikeda; Takanari Kitazono
Journal:  J Endocrinol Invest       Date:  2014-07-05       Impact factor: 4.256

Review 3.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

Review 4.  Nonthyroidal illness syndrome in children.

Authors:  Seth D Marks
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

5.  Response of hepatic mitochondrial alpha-glycerophosphate dehydrogenase and malic enzyme to constant infusions of L-triiodothyronine in rats bearing the Walker 256 carcinoma. Evidence for divergent postreceptor regulation of the thyroid hormone response.

Authors:  J M Tibaldi; N Sahnoun; M I Surks
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

6.  A longitudinal evaluation of thyroid function in critically ill surgical patients.

Authors:  G P Zaloga; B Chernow; R C Smallridge; R Zajtchuk; K Hall-Boyer; R Hargraves; C R Lake; K D Burman
Journal:  Ann Surg       Date:  1985-04       Impact factor: 12.969

7.  Transient Hyperthyrotropinemia in Outpatient Children with Acute Infections of the Respiratory System.

Authors:  Katarzyna Adamczewska; Zbigniew Adamczewski; Magdalena Stasiak; Andrzej Lewiński; Renata Stawerska
Journal:  Int J Environ Res Public Health       Date:  2021-04-13       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.